These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6800069)

  • 1. In vivo diminution by chelators of snake venom-provoked hemorrhage and in vitro inhibition of proteolytic activity.
    Giroux E; Lachmann PJ
    Toxicon; 1981; 19(4):481-92. PubMed ID: 6800069
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemorrhage induced by snake venoms.
    Tu AT
    Taiwan Yi Xue Hui Za Zhi; 1982 Jul; 81(7):807-18. PubMed ID: 6754858
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel in vitro assays for assessing the haemorrhagic activity of snake venoms and for demonstration of venom metalloproteinase inhibitors.
    Bee A; Theakston RD; Harrison RA; Carter SD
    Toxicon; 2001 Sep; 39(9):1429-34. PubMed ID: 11384733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two methods for proteolytic enzyme detection in snake venom.
    Markland FS; Perdon A
    Toxicon; 1986; 24(4):385-93. PubMed ID: 3087029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhagic, fibrinogenolytic and edema-forming activities of the venom of the colubrid snake Philodryas olfersii (green snake).
    Assakura MT; Salomão MG; Puorto G; Mandelbaum FR
    Toxicon; 1992 Apr; 30(4):427-38. PubMed ID: 1626324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The properties of the purified fibrinolytic principle from Agkistrodon acutus snake venom.
    Ouyang C; Huang TF
    Toxicon; 1977; 15(2):161-7. PubMed ID: 193216
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators.
    Howes JM; Theakston RD; Laing GD
    Toxicon; 2007 Apr; 49(5):734-9. PubMed ID: 17196631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and biological analysis of Philodryas baroni (Baron's green racer; Dipsadidae) venom: relevance to the findings of human risk assessment.
    Sánchez MN; Timoniuk A; Maruñak S; Teibler P; Acosta O; Peichoto ME
    Hum Exp Toxicol; 2014 Jan; 33(1):22-31. PubMed ID: 23800999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of heat-stable hemorrhagic toxins in snake venoms.
    Ownby CL; Colberg TR; Li Q
    Toxicon; 1994 Aug; 32(8):945-54. PubMed ID: 7985199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The toxic Duvernoy's secretion of the wandering garter snake, Thamnophis elegans vagrans.
    Vest DK
    Toxicon; 1981; 19(6):831-9. PubMed ID: 7336444
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of calcium on proteolytic activity and conformation of hemorrhagic toxin I from five pace snake (Agkistrodon acutus) venom.
    Zhang JJ; Chen ZX; He YZ; Xu X
    Toxicon; 1984; 22(6):931-5. PubMed ID: 6395446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of hemorrhagic snake venoms by sera of Trimeresurus flavoviridis (Habu), Herpestes edwardsii (mongoose) and Dinodon semicarinatus (Akamata).
    Tomihara Y; Kawamura Y; Yonaha K; Nozaki M; Yamakawa M; Yoshida C
    Toxicon; 1990; 28(8):989-91. PubMed ID: 2080520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA.
    Rucavado A; Escalante T; Franceschi A; Chaves F; León G; Cury Y; Ovadia M; Gutiérrez JM
    Am J Trop Med Hyg; 2000; 63(5-6):313-9. PubMed ID: 11421384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effect of the Plant Extracts of Erythroxylum sp. against Toxic Effects Induced by the Venom of Lachesis muta Snake.
    Coriolano de Oliveira E; Alves Soares Cruz R; de Mello Amorim N; Guerra Santos M; Carlos Simas Pereira Junior L; Flores Sanchez EO; Pinho Fernandes C; Garrett R; Machado Rocha L; Lopes Fuly A
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27727185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro dissolution of calcium oxalate stones with ethylenediaminetetraacetic acid and snake venom thrombin-like enzyme.
    Zhou XJ; Zhang J; Zhang C; Xu CG
    Urol Int; 2014; 92(3):349-55. PubMed ID: 24246673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological significance and therapeutic applications of snake venom protease inhibitors.
    Thakur R; Mukherjee AK
    Toxicon; 2017 Jun; 131():37-47. PubMed ID: 28288936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of metals in snake venoms for hemorrhagic, esterase and proteolytic activities.
    Friederich C; Tu AT
    Biochem Pharmacol; 1971 Jul; 20(7):1549-56. PubMed ID: 5005831
    [No Abstract]   [Full Text] [Related]  

  • 18. Triterpenoid saponins, new metalloprotease snake venom inhibitors isolated from Pentaclethra macroloba.
    da Silva JO; Fernandes RS; Ticli FK; Oliveira CZ; Mazzi MV; Franco JJ; Giuliatti S; Pereira PS; Soares AM; Sampaio SV
    Toxicon; 2007 Aug; 50(2):283-91. PubMed ID: 17517426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chelating agents on the excretion of endogenous metals.
    Cantilena LR; Klaassen CD
    Toxicol Appl Pharmacol; 1982 May; 63(3):344-50. PubMed ID: 6285552
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of hemorrhagic activities of various snake venoms by purified antihemorrhagic factor obtained from Japanese Habu snake.
    Omori-Satoh T; Nagaoka Y; Yamakawa Y; Mebs D
    Toxicon; 1994 Mar; 32(3):365-8. PubMed ID: 8016857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.